New Phase I trial data finds that people who responded to ELI-002 survived longer and stayed cancer-free longer than usual. Reading time 2 minutes An experimental “off-the-shelf” vaccine for recurring ...
A next-generation obesity shot from Eli Lilly & Co. helped patients lose almost a quarter of their body weight, potentially making the experimental drug the most potent weight-loss medicine yet. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback